{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:25:24Z","timestamp":1725755124329},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,7]]},"DOI":"10.7759\/cureus.68860","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T12:00:38Z","timestamp":1725710438000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Complexities and Management of Gouty Arthritis With Suspected Seronegative Rheumatoid Arthritis and Malignancy in an Elderly Male"],"prefix":"10.7759","author":[{"given":"Sai Pritam","family":"Keelapattu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Bangaragiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya Sai","family":"Eada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0878-5","article-title":"The genetics of gout: towards personalised medicine?","volume":"15","author":"Dalbeth N","year":"2017","unstructured":"Dalbeth N, Stamp LK, Merriman TR. The genetics of gout: towards personalised medicine?. BMC Med. 2017, 15:108. 10.1186\/s12916-017-0878-5","journal-title":"BMC Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette P","year":"2010","unstructured":"Richette P, Bardin T. Gout. Lancet. 2010, 375:318-28. 10.1016\/S0140-6736(09)60883-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes IB","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365:2205-19. 10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep086","article-title":"New insights into the epidemiology of gout","volume":"48 Suppl 2","author":"Doherty M","year":"2009","unstructured":"Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford). 2009, 48 Suppl 2:ii2-8. 10.1093\/rheumatology\/kep086","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag KG","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, et al.. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008, 59:762-84. 10.1002\/art.23721","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2014.05.002","article-title":"Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis","volume":"81","author":"Gaujoux-Viala C","year":"2014","unstructured":"Gaujoux-Viala C, Gossec L, Cantagrel A, et al.. Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. Joint Bone Spine. 2014, 81:287-97. 10.1016\/j.jbspin.2014.05.002","journal-title":"Joint Bone Spine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.997213","article-title":"Advances in pharmacotherapy for the treatment of gout","volume":"16","author":"Robinson PC","year":"2015","unstructured":"Robinson PC, Dalbeth N. Advances in pharmacotherapy for the treatment of gout. Expert Opin Pharmacother. 2015, 16:533-46. 10.1517\/14656566.2015.997213","journal-title":"Expert Opin Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269172-diagnostic-complexities-and-management-of-gouty-arthritis-with-suspected-seronegative-rheumatoid-arthritis-and-malignancy-in-an-elderly-male","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T12:00:41Z","timestamp":1725710441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269172-diagnostic-complexities-and-management-of-gouty-arthritis-with-suspected-seronegative-rheumatoid-arthritis-and-malignancy-in-an-elderly-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.68860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,7]]}}}